Microsoft
Microsoft, the second-largest company by market capitalization on Wall Street (after Apple) and developer of the operating system known as Windows and the Office suite, is scheduled to report its results for the quarter ended December 2021 on Tuesday, January 25, after the market closes. Zacks forecasts sales for the quarter at $50.32 billion, above the $43.08 billion in the year-ago period (up 16.82%), while the return per share is expected to be $2.29, above the $2.03 in the year-ago quarter (an increase of 12.81%.)
For revenue by product line for the coming quarter, Amy Hood Microsoft CFO forecasts growth from Q1, with Business Processes segment led by Office and other software. Revenue is expected to be between $15.7 and $15.95 billion, up from $15.03 billion. The Intelligent Cloud group, led by Azure, is expected to earn between $18.1 and $18.35 billion, up from $16.96 billion, and other Personal Computing segments, which include Windows, Surface and Xbox are projected at $16.35 billion and $16.75 billion, up from $13.31 billion.
Meanwhile, ahead of next week’s earnings report, Microsoft created a sensation when it announced that it will acquire video game giant Activision Blizzard maker and distributor of popular video games like Call of Duty, World of Warcraft, Diablo and Candy Crush, for $68.7 billion. This will make Microsoft the world’s third-largest gaming company by revenue, behind only Tencent and Sony, and it’s a major bet on its entry into the Metaverse world, with the acquisition following Activision’s woes after 700 employees protested over sexual harassment and discrimination since July 2021.
Although the earnings outlook is positive, #Microsoft’s stock price since the beginning of the year until now has dropped more than 10%, a drop in line with the overall market trend, especially in technology stocks. However, the company’s share price is falling near the key support zone at the MA200 line at 293.00; if it can break down there will be next support in the 280.00 zones. Conversely, if the company’s earnings are strong, it may push the company’s share price back to the 320.00 zones again.
Johnson & Johnson
Johnson & Johnson, the largest and most diversified healthcare company in the world valued at $437 billion, is another company due to report fourth-quarter results on Monday, January 25, ahead of the market open. Zacks forecasts sales of $25.26 billion, up from $22.48 billion during the same period of the previous year (up 12.37%), while return per share is expected to be $2.12, up from $1.86 in the year-ago quarter (an increase of 13.98%). J&J’s return per share has exceeded Zacks’ expectations in every quarter since Q3 2012, while sales were lower than expected in only 2 of the last 10 quarters.
An interesting move during J&J’s fourth quarter was the change of CEO earlier this month, with Joaquin Duato replacing Alex Gorsky, who has been CEO since 2012, while last November the company announced plans to split J&J into two companies; one that will focus on consumer health. and another that will focus on drugs and medical devices.
ที่มา: COVID Data Tracker
J&J didn’t seem to benefit much from the arrival of the Omicron strain in Q4, as the J&J vaccine was not popular in the United States. The proportion of J&J vaccinations is less than 4% of the total number of doses administered in the US, lower than Pfizer or Moderna.
The share price of #Johnson&Johnson is down 3.4% since the beginning of the year after reaching a high of 174.00 and closing below the MA200 on Thursday, making the company’s share price trend now somewhat bearish on the Channel frame. This corresponds to the MACD which is about to cross the 0 line and the RSI which is at 37. If the 4th quarter results come below market expectations, we may see the company’s share price return to the quarter’s low zone again at 156.00, while a good report could see the company’s share price test the 174.00 high again.
Disclaimer: Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of purchase or sale of any financial instrument.
Recommended content
Editors’ Picks
EUR/USD holds above 1.0700 ahead of key US data
EUR/USD trades in a tight range above 1.0700 in the early European session on Friday. The US Dollar struggles to gather strength ahead of key PCE Price Index data, the Fed's preferred gauge of inflation, and helps the pair hold its ground.
USD/JPY stays above 156.00 after BoJ Governor Ueda's comments
USD/JPY holds above 156.00 after surging above this level with the initial reaction to the Bank of Japan's decision to leave the policy settings unchanged. BoJ Governor said weak Yen was not impacting prices but added that they will watch FX developments closely.
Gold price oscillates in a range as the focus remains glued to the US PCE Price Index
Gold price struggles to attract any meaningful buyers amid the emergence of fresh USD buying. Bets that the Fed will keep rates higher for longer amid sticky inflation help revive the USD demand.
Sei Price Prediction: SEI is in the zone of interest after a 10% leap
Sei price has been in recovery mode for almost ten days now, following a fall of almost 65% beginning in mid-March. While the SEI bulls continue to show strength, the uptrend could prove premature as massive bearish sentiment hovers above the altcoin’s price.
US core PCE inflation set to signal firm price pressures as markets delay Federal Reserve rate cut bets
The core PCE Price Index, which excludes volatile food and energy prices, is seen as the more influential measure of inflation in terms of Fed positioning. The index is forecast to rise 0.3% on a monthly basis in March, matching February’s increase.